
Autrefois une niche relativement restreinte et quelque peu obscure, les transactions secondaires en private equity font désormais partie intégrante de l’écosystème global du private equity. Les stratégies secondaires peuvent offrir une diversification significative entre gérants, secteurs, zones géographiques, stratégies et millésimes.
Mais qu’entend-on exactement par transactions secondaires? Comment cette sous-classe d’actifs surperforme-t-elle constamment les marchés cotés et offre-t-elle une faible volatilité? Et comment une allocation à ce segment peut-elle améliorer un portefeuille?
- Luxury cruising at its finest
- Experience luxury
- Washington Weekly: Reciprocal Discussions
- Highlights from the M&A DACH Summit
- The first 100 days
- ¶·Å£ÆåÅÆÔÚÏß Trending: Tariffs impact on international economies
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- Steering through market uncertainty
- TRTPM monthly blog – Edition April 2025
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Trump has constraints
- Comment Bentour relève les défis et continue de croître
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Unified Global Alternatives – Hedge Fund Bulletin
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
- Will AI doctors disrupt drug commercialization?
Vous souhaitez recevoir plus d’informations?
Vous souhaitez recevoir plus d’informations?
Abonnez-vous pour recevoir les dernières perspectives et informations sur les marchés privés dans tous les secteurs directement dans votre boîte de réception.
Contactez-nous
Présentation de notre équipe de direction
Faites connaissance avec les membres de l’équipe responsable de l’orientation stratégique d’¶·Å£ÆåÅÆÔÚÏß Asset Management.